UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
Commission File Number: 001-38145
Fury Gold Mines Limited(Translation of registrant's name into English)
1630-1177 West Hastings StreetVancouver, BC, V6E 2K3 Canada(Address of principal executive office)
Indicate by check mark whether the registrant files or will... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 27, 2026
XCF GLOBAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 001-42687 33-4582264 (State or other jurisdiction of... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 27, 2026
MapLight Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-42914 83-2163243
(State or other... (continue reading...)
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 27, 2026
Neumora Therapeutics, Inc.
(Exact name of Registrant as Specified in Its Charter)
Delaware
... (continue reading...)More SEC Filings
View Older Stories-
Form 8-K XCF Global, Inc. For: Jul 27
-
Form 6-K Alithya Group inc For: Jul 27
-
Form 4 Smart Sand, Inc. For: Jul 23 Filed by: Green Christopher M.
-
Form S-4/A XCF Global, Inc.
-
Form 8-K HBT Financial, Inc. For: Jul 24
-
Form 8-K EXPAND ENERGY Corp For: Jul 27
-
Form 8-K D-Wave Quantum Inc. For: Jul 27
-
Form 8-K Camp4 Therapeutics Corp For: Jul 27
-
Form 8-K XPO, Inc. For: Jul 24
-
Form 8-K LAKELAND FINANCIAL CORP For: Jul 27
-
Form 8-K LAKELAND FINANCIAL CORP For: Jul 27
-
Form D Brantone Veylor Inc
-
Form 6-K OKYO Pharma Ltd For: Jul 27
-
Form N-PX HFM Investment Advisors, For: Jun 30
-
Form S-1/A Apnimed, Inc.
-
Form 6-K ASTRAZENECA PLC For: Jul 27
-
Form 4 UNITED THERAPEUTICS Corp For: Jul 24 Filed by: ROTHBLATT MARTINE A
-
Form D SleepRes, Inc.
-
Form 8-K SPX Technologies, Inc. For: Jul 24
-
Form 6-K Ferrari N.V. For: Jul 24
-
Form 6-K RYANAIR HOLDINGS PLC For: Jul 27
-
Form 6-K BANCO BILBAO VIZCAYA For: Jul 27
-
Form N-PX CoreView Capital Managem For: Jun 30
-
Form D/A CTLD Growth & Income
-
Form 424B5 NANOVIRICIDES, INC.
-
Form 6-K Perfect Corp. For: Jul 27
-
Form 6-K PRUDENTIAL PLC For: Jul 27
-
Form N-PX IvyRock Asset Management For: Jun 30
-
Form SC14D9C Forte Biosciences, Inc. Filed by: Forte Biosciences, Inc.
-
Form SC14D9C Forte Biosciences, Inc. Filed by: Forte Biosciences, Inc.
-
Form 10-Q Clean Energy Technologie For: Mar 31
-
Form 4 Greenwich LifeSciences, For: Jul 23 Filed by: Patel Snehal
-
Form D SUMITOMO MITSUI FINANCIA
-
Form S-4/A ONE Nuclear Energy LLC Filed by: Hennessy Capital Investment Corp. VII
-
Form 425 Evernorth Holdings Inc. Filed by: Evernorth Holdings Inc.
-
Form 6-K Sanofi For: Jul 27
-
Form S-4/A NON INVASIVE MONITORING
-
Form 8-K Profusa, Inc. For: Jul 27
-
Form 6-K The9 LTD For: Jul 27
-
Form 8-K ENSIGN GROUP, INC For: Jul 27
-
Form 8-K Baker Hughes Co For: Jul 26
-
Form 4 36Kr Holdings Inc. For: Jul 01 Filed by: Feng Dagang
-
Form 6-K ICICI BANK LTD For: Jul 24
-
Form 6-K ERICSSON LM TELEPHONE For: Jul 27
-
Form 13F-HR Shengqi Capital (Hong For: Jun 30
-
Form 6-K Radiopharm Theranostics For: Jul 27
-
Form 8-K Forte Biosciences, Inc. For: Jul 26
-
Form 424B5 NANOVIRICIDES, INC.
-
Form 6-K Li Auto Inc. For: Jul 27
-
Form DEFA14A FLEX LTD.
